NasdaqCM - Delayed Quote USD
Aytu BioPharma, Inc. (AYTU)
Tune into earnings calls Now streaming directly on quote pages.
1.3500
+0.0400
+(3.05%)
At close: May 14 at 4:00:00 PM EDT
1.8702
+0.52
+(38.53%)
Pre-Market: 8:53:43 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 173.5k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| PYSZCZYMUKA GREG Officer | -- | Direct | -- | Mar 31, 2025 |
| DISBROW JOSHUA R. Chief Executive Officer | Purchase at price 1.30 per share. | Direct | 19,500 | Feb 28, 2025 |
| SELHORN RYAN J Chief Financial Officer | -- | Direct | -- | Feb 5, 2025 |
| PYSZCZYMUKA GREG Officer | -- | Direct | -- | Dec 31, 2024 |
| SELHORN RYAN J Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 11, 2024 |
| LIU VIVIAN H Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 6, 2024 |
| DOCKERY CARL C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 6, 2024 |
| JAIN ABHINAV Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 6, 2024 |
| PYSZCZYMUKA GREG Officer | -- | Direct | -- | Sep 30, 2024 |
| PYSZCZYMUKA GREG Officer | -- | Direct | -- | Jun 28, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 2.85 per share. | Indirect | 2,323,368 | Jun 14, 2024 |
| PYSZCZYMUKA GREG Officer | -- | Direct | -- | Mar 28, 2024 |
| PYSZCZYMUKA GREG Officer | -- | Direct | -- | Dec 29, 2023 |
| PYSZCZYMUKA GREG Officer | -- | Direct | -- | Sep 29, 2023 |
| JAIN ABHINAV Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 16, 2023 |
| LIU VIVIAN H Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 11, 2023 |
| LIU VIVIAN H Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 11, 2023 |
| DOCKERY CARL C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 11, 2023 |
| JAIN ABHINAV Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 11, 2023 |
| PYSZCZYMUKA GREG Officer | -- | Direct | -- | Jun 30, 2023 |
| PYSZCZYMUKA GREG Officer | Purchase at price 1.87 per share. | Direct | 22,428 | Jun 16, 2023 |
| DISBROW JOSHUA R. Chief Executive Officer | Purchase at price 1.86 per share. | Direct | 26,079 | Jun 14, 2023 |
Related Tickers
PRFX PainReform Ltd.
1.9600
+2.08%
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.2333
+12.11%
INM InMed Pharmaceuticals Inc.
3.3600
+28.24%
UPC Universe Pharmaceuticals INC
4.9100
-4.10%
APUS Apimeds Pharmaceuticals US, Inc
1.8600
+6.29%
DERM Journey Medical Corporation
5.97
-5.54%
PTPI Petros Pharmaceuticals, Inc.
0.1400
+10.41%
ETON Eton Pharmaceuticals, Inc.
17.12
+0.29%
RDHL RedHill Biopharma Ltd.
1.8800
-0.53%
ZYBT Zhengye Biotechnology Holding Limited
8.44
+13.90%